REV7 confers radioresistance of esophagus squamous cell carcinoma by recruiting PRDX2

Radiotherapy has been widely used for the clinical management of esophageal squamous cell carcinoma. However, radioresistance remains a serious concern that prevents the efficacy of esophageal squamous cell carcinoma (ESCC) radiotherapy. REV7, the structural subunit of eukaryotic DNA polymerase ζ, h...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Cheng, Luo, Judong, Lu, Xujing, Tang, Yiting, Ma, Yan, Yun, Yifei, Cao, Jianping, Cao, Juhua, Huang, Zeyu, Zhou, Xifa, Zhang, Shuyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398896/
https://www.ncbi.nlm.nih.gov/pubmed/30657231
http://dx.doi.org/10.1111/cas.13946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398896/
https://www.ncbi.nlm.nih.gov/pubmed/30657231
http://dx.doi.org/10.1111/cas.13946

Ejemplares similares